Table 1. Bacterial strains and plasmids used in this study.
Name | Descriptiona | Reference |
---|---|---|
E. faecalis | ||
DS5 | Cytolysin-positive clinical isolate | 48 |
E1Sol | Gelatinase-positive commensal strain | 49 |
CH188 | Gelatinase- and cytolysin-negative clinical isolate | 43 |
X98 | Cytolysin-positive isolate | 50 |
JH2-2 | Gelatinase- and cytolysin-negative laboratory strain | 21 |
T2 | Gelatinase- and cytolysin-negative clinical isolate | 42 |
MMH594 | Gelatinase- and cytolysin-positive clinical isolate | 51 |
V583 | Gelatinase-positive clinical isolate | 44 |
V583fsrB* | E. faecalis V583 with an amber point mutation in the fsrB codon that causes the loss of GBAP production; gelatinase-negative phenotype | Leanti La Rosa et al, submitted |
V583ΔgelE | E. faecalis V583 gelE mutant; produces GBAP but has a gelatinase-negative phenotype | 45 |
SL11 | E. faecalis MMH594::pREG696 luxPgelE | This study |
SL13 | E. faecalis MMH594::pREG696 luxPfsrB | This study |
JH2-2 CBS | E. faecalis JH2-2::pSL101cylR2R1Pcyl | This study |
T2 CBS | E. faecalis T2::pSL101cylR2R1Pcyl | This study |
V583fsrB* GBS | E. faecalis V583 fsrB*::pREG696 luxPgelE | This study |
X98 pMG36c | E. faecalis ×98:: pMG36c | This study |
X98 pCG | E. faecalis ×98:: pCG | This study |
Plasmids | ||
pSL101cylR2R1Pcyl | Spcr, contains the axe-txe cassette and the luxABCDE operon under the control of the Pcyl promoter and the regulatory genes cylR2 and cylR1 | 18 |
pREG696 luxPgelE | Spcr, contains the gelE promoter fused to the luxABCDE operon | 18 |
pREG696 luxPfsrB | Spcr, contains the fsrB promoter fused to the luxABCDE operon | 45 |
pMG36c | Camr, | 52 |
pCG | Camr | 53 |
aSpcr, spectinomycin resistance; Camr, chloramphenicol resistance.